OALib Journal期刊
ISSN: 2333-9721
费用:99美元
|
|
|
A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)
DOI: 10.1016/j.tranon.2019.02.007
Di Wu, Fang Lou, Haiyan Wu, Hongming Pan, Jianfeng Li, Jiwei Liu, Jun Ge, Jun Guo, Lili Mao, Lingjun Zhu, Lu Si, Scott J. Diede, Shijie Lan, Xiaoshi Zhang, Xin Cai, Xizhi Wen, Xuan Wang, Yanhong Gu, Yongqian Shu, Yu Zhou
Abstract:
Full-Text
|
|
Contact Us
service@oalib.com QQ:3279437679 
WhatsApp +8615387084133
|
|